You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MELT-300

Showing 1 - 25 of 2,336
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cataract Trial in Rancho Cordova, Jacksonville, W. Fargo (MELT-300, Midazolam alone, Ketamine alone)

Completed
  • Cataract
  • MELT-300
  • +3 more
  • Rancho Cordova, California
  • +2 more
Dec 15, 2022

Solid Tumors Trial in Worldwide (AZD2281)

Active, not recruiting
  • Solid Tumors
  • Randwick, Australia
  • +7 more
Dec 19, 2022

Sterile Corneal Melt Trial in Montreal (Topical Infliximab)

Recruiting
  • Sterile Corneal Melt
  • Topical Infliximab
  • Montreal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal
Dec 12, 2022

Microbial Colonization Trial in Dunedin (Probiotic Streptococcus salivarius K12 Fast Melt Powder 1 Billion colony forming units

Recruiting
  • Microbial Colonization
  • Probiotic Streptococcus salivarius K12 Fast Melt Powder 1 Billion colony forming units /g)
  • Probiotic Streptococcus salivarius K12 Fast Melt Powder 100 Million colony forming units /g)
  • Dunedin, Otago, New Zealand
    Blis Technologies Ltd
May 5, 2022

Healthy Trial (TYRA-300-B01)

Not yet recruiting
  • Healthy
  • (no location specified)
Aug 17, 2023

Diabetic Neuropathies, Diabetes, Dietary Supplement Trial in Thessaloníki (Epineuron, Placebo group)

Completed
  • Diabetic Neuropathies
  • +2 more
  • Epineuron
  • Placebo group
  • Thessaloníki, Thessaloniki, Greece
    University General Hospital AHEPA
Aug 8, 2023

Knee Osteoarthritis Trial in Cairo (routine physiotherapy program for knee osteoarthritis, Retro-walking program, whole body

Completed
  • Knee Osteoarthritis
  • routine physiotherapy program for knee osteoarthritis
  • +2 more
  • Cairo, Egypt
    Faculty of Physical Therapy
Oct 26, 2023

Type 2 Diabetes, Renal Impairment Trial in Worldwide (Insulin glargine 300 U/mL, Insulin degludec 100 U/mL)

Recruiting
  • Type 2 Diabetes Mellitus
  • Renal Impairment
  • Insulin glargine 300 U/mL
  • Insulin degludec 100 U/mL
  • Yuma, Arizona
  • +62 more
Dec 14, 2022

Anesthesia Trial in Sioux Falls (Midazolam/Ketamine HCl 3mg-50mg sublingual, Midazolam 3mg Sublingual, Ketamine 50mg Sublingual)

Unknown status
  • Anesthesia
  • Midazolam/Ketamine HCl 3mg-50mg sublingual
  • +2 more
  • Sioux Falls, South Dakota
    Vance Thompson Vision
Jan 22, 2021

Submental Fat Trial in San Diego (10XB-101 Solution for Injection)

Active, not recruiting
  • Submental Fat
  • 10XB-101 Solution for Injection
  • San Diego, California
    Site 01
Nov 17, 2021

MDD Trial in Phoenix, Yuma, Okeechobee (ALTO-300, Placebo)

Recruiting
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +2 more
Jun 19, 2023

Child Behavioral Health Trial in Masaka (Economic Empowerment (EE), Multiple Family Group based Family Strengthening (MFG-based

Recruiting
  • Child Behavioral Health
  • Economic Empowerment (EE)
  • +2 more
  • Masaka, Uganda
    International Center for Child Health and Development
Dec 12, 2022

Crohn's Disease Trial (Vedolizumab IV, Placebo)

Not yet recruiting
  • Crohn's Disease
  • Vedolizumab IV
  • Placebo
  • (no location specified)
Apr 20, 2023

COVID-19, Long COVID, Pulmonary Fibrosis Trial in Aurora, New York, Houston (BIO 300 Oral Suspension, Placebo)

Recruiting
  • COVID-19
  • +4 more
  • BIO 300 Oral Suspension
  • Placebo
  • Aurora, Colorado
  • +3 more
Aug 1, 2022

Dentin Hypersensitivity Trial in Melaka Tengah (Grape Seed Extract, Low-level laser therapy)

Recruiting
  • Dentin Hypersensitivity
  • Grape Seed Extract
  • Low-level laser therapy
  • Melaka Tengah, Melaka, Malaysia
    Manipal University College Malaysia
Jun 25, 2023

Vascular Structure, Vascular Function and Vascular Aging in

Recruiting
  • Persistent COVID-19
  • +3 more
    • Salamanca, Spain
      Primary Care Research Unit of Salamanca (APISAL)
    Apr 18, 2023

    Advanced Tumors Trial in United States (CPI-300)

    Recruiting
    • Advanced Tumors
    • Scottsdale, Arizona
    • +3 more
    Jul 19, 2022

    Ankylosing Spondylitis Trial in United States (150 mg open-label secukinumab, 150 mg double-blinded secukinumab, 300 mg

    Completed
    Has Results
    • Ankylosing Spondylitis
    • 150 mg open-label secukinumab
    • +2 more
    • Jonesboro, Arkansas
    • +64 more
    Apr 27, 2022

    Type 1 Diabetes Trial in Worldwide (Insulin glargine, 300 U/ml, Insulin degludec, 100U/ml, Background therapy: Rapid acting

    Completed
    Has Results
    • Type 1 Diabetes Mellitus
    • Insulin glargine, 300 U/ml
    • +2 more
    • Dallas, Texas
    • +6 more
    Oct 19, 2022

    Type 2 Diabetes Trial in Jaipur, Nasik (Insulin glargine (U300))

    Recruiting
    • Type 2 Diabetes Mellitus
    • Insulin glargine (U300)
    • Jaipur, India
    • +1 more
    Aug 18, 2022

    Type 2 Diabetes (T2DM) Trial in Germany

    Recruiting
    • Type 2 Diabetes Mellitus (T2DM)
      • Germany, Germany
        Investigational site
      Nov 21, 2022

      OCT Agreement and Precision Study

      Completed
      • Normal Eyes
      • +2 more
        • Jamaica, New York
          New York VA
        Jun 6, 2022

        Atopic Dermatitis Trial in Newark (BSI-045B, Dupilumab)

        Not yet recruiting
        • Atopic Dermatitis
        • Newark, Delaware
          Biosion USA, Inc.
        Jul 7, 2023

        Glycemic Control and Quality of Life in Type 1 Diabetes During

        Completed
        • Type 1 Diabetes
        • Insulin Glargine 300 UNT/ML [Toujeo]
        • Aalst, Belgium
        • +2 more
        Aug 29, 2022

        Ischemic Stroke Trial in Kafr Ash Shaykh (Ticagrelor 90 MG, Clopidogrel)

        Recruiting
        • Ischemic Stroke
        • Kafr Ash Shaykh, Egypt
          Kafr Elsheikh University Hospital
        Nov 7, 2023